119 related articles for article (PubMed ID: 16142631)
1. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots.
Woelkart K; Xu W; Pei Y; Makriyannis A; Picone RP; Bauer R
Planta Med; 2005 Aug; 71(8):701-5. PubMed ID: 16142631
[TBL] [Abstract][Full Text] [Related]
2. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
3. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
4. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
De Petrocellis L; Di Marzo V
J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
[TBL] [Abstract][Full Text] [Related]
5. The role of alkamides as an active principle of echinacea.
Woelkart K; Bauer R
Planta Med; 2007 Jun; 73(7):615-23. PubMed ID: 17538868
[TBL] [Abstract][Full Text] [Related]
6. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level.
Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G
Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids selectively enhance sweet taste.
Yoshida R; Ohkuri T; Jyotaki M; Yasuo T; Horio N; Yasumatsu K; Sanematsu K; Shigemura N; Yamamoto T; Margolskee RF; Ninomiya Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):935-9. PubMed ID: 20080779
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cannabinoid receptor activity of ketoalkenes from Echinacea pallida and nonnatural analogues.
Egger M; Pellett P; Nickl K; Geiger S; Graetz S; Seifert R; Heilmann J; König B
Chemistry; 2008; 14(35):10978-84. PubMed ID: 18979494
[TBL] [Abstract][Full Text] [Related]
9. Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors.
Hohmann J; Rédei D; Forgo P; Szabó P; Freund TF; Haller J; Bojnik E; Benyhe S
Phytochemistry; 2011 Oct; 72(14-15):1848-53. PubMed ID: 21764086
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptors and their ligands: ligand-ligand and ligand-receptor modeling approaches.
Reggio PH
Handb Exp Pharmacol; 2005; (168):247-81. PubMed ID: 16596777
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors.
Govaerts SJ; Muccioli GG; Hermans E; Lambert DM
Eur J Pharmacol; 2004 Jul; 495(1):43-53. PubMed ID: 15219819
[TBL] [Abstract][Full Text] [Related]
12. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans.
Woelkart K; Koidl C; Grisold A; Gangemi JD; Turner RB; Marth E; Bauer R
J Clin Pharmacol; 2005 Jun; 45(6):683-9. PubMed ID: 15901750
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for cannabinoid receptor probes.
Thakur GA; Nikas SP; Li C; Makriyannis A
Handb Exp Pharmacol; 2005; (168):209-46. PubMed ID: 16596776
[TBL] [Abstract][Full Text] [Related]
15. Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB₁ receptor ligand.
Ligresti A; Villano R; Allarà M; Ujváry I; Di Marzo V
Pharmacol Res; 2012 Aug; 66(2):163-9. PubMed ID: 22525682
[TBL] [Abstract][Full Text] [Related]
16. Update on the endocannabinoid system as an anticancer target.
Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M
Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
18. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
[TBL] [Abstract][Full Text] [Related]
19. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects.
Raduner S; Majewska A; Chen JZ; Xie XQ; Hamon J; Faller B; Altmann KH; Gertsch J
J Biol Chem; 2006 May; 281(20):14192-206. PubMed ID: 16547349
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.
Duarte CD; Tributino JL; Lacerda DI; Martins MV; Alexandre-Moreira MS; Dutra F; Bechara EJ; De-Paula FS; Goulart MO; Ferreira J; Calixto JB; Nunes MP; Bertho AL; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2007 Mar; 15(6):2421-33. PubMed ID: 17275312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
